|
Cempra Underwhelms in Nasdaq Debut
NCTechNews (press release) (Chapel Hill, NC) Cempra (CEMP), a Chapel Hill pharmaceutical firm debuting in 2006, went public on the Nasdaq late last week raising $ 50.4 million in an 8.4 million share offering at $ 6 per share, well below its target range of $ 11 to $ 13. |